Search

everythinglearnresearchcommunity

for

Search:↓

Many people with alopecia experience high levels of social anxiety, anxiety, and depression, and while wigs can boost confidence, they may also cause anxiety.

Skin problems are very common in people with end-stage kidney disease.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Hidradenitis suppurativa treatment should be tailored to the individual, with quitting smoking being important.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Betamethasone valerate foam is more effective and safe for treating mild-to-moderate alopecia areata than betamethasone dipropionate lotion.

Finding eosinophils near hair bulbs helps diagnose alopecia areata.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Sexual activity can spread T. interdigitale, needing quick antifungal treatment to avoid permanent scarring.

Squarticles effectively deliver hair growth drugs to follicles and dermal papilla cells.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Most patients with chronic kidney disease have skin problems, which get worse as the disease progresses, and dialysis doesn't greatly reduce these issues.

Tight hairstyles and chemical relaxers can cause hair loss known as traction alopecia.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

The article explains the genetic causes and symptoms of various hair disorders and highlights the need for more research to find treatments.

Nearly half of children with primary immunodeficiency disorders showed skin problems, often as the first sign of their condition.

Using both vertical and transverse sections gives a better diagnosis of alopecia than using one method alone.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Low level laser therapy works best for hair loss, followed by PRP, finasteride, and minoxidil.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

Scarring alopecia affects different hair follicle stem cells than nonscarring alopecia, and the infundibular region could be a new treatment target.

Dermatologists are more accurate than general practitioners in diagnosing skin conditions, especially skin cancer.

3% topical minoxidil effectively treats extensive alopecia areata with few side effects.

KFSD is a rare condition causing scarring hair loss, with no effective treatment known at the time of the report.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Other common signs, not just the well-known immune cells around hair bulbs, are important for diagnosing hair loss from alopecia areata.

Chemotherapy often causes patterned hair loss, with some scalp areas more resistant to hair loss than others.